New hope to stop cervical cancer in High-Risk women
NCT ID NCT06519994
Summary
This study is testing whether a vaginal insert (artesunate) can help clear HPV infection and prevent cervical precancer from returning in women living with HIV. It aims to improve the success of standard thermal ablation treatment, which often fails in this high-risk group. The trial involves 120 women in Kenya who will use the insert or a placebo for several weeks and be followed for six months to see if their HPV clears.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lumumba Sub-County Hospital KEMRI- Research Care Training Program (RCTP) Building
Kisumu, 614-40100, Kenya
Conditions
Explore the condition pages connected to this study.